BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3418289)

  • 1. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload.
    Pye G; Christie M; Chamberlain JO; Moss SM; Hardcastle JD
    J Epidemiol Community Health; 1988 Mar; 42(1):66-71. PubMed ID: 3418289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.
    Macrae FA; St John DJ; Ambikapathy A; Sharpe K; Garner JF
    Med J Aust; 1986 Jun; 144(12):621-3. PubMed ID: 3713601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of compliance with screening for colorectal cancer.
    Nichols S; Koch E; Lallemand RC; Heald RJ; Izzard L; Machin D; Mullee MA
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):107-10. PubMed ID: 3089411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France).
    Launoy G; Veret JL; Richir B; Reaud JM; Ollivier V; Valla A; Gignoux M
    Eur J Cancer Prev; 1993 May; 2(3):229-32. PubMed ID: 8490541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
    Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
    Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for asymptomatic bowel cancer in general practice.
    Lallemand RC; Vakil PA; Pearson P; Box V
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):31-3. PubMed ID: 6418307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues impacting on acceptance and compliance in a community based colorectal screening program.
    Gordon D; Doty GL
    Prog Clin Biol Res; 1987; 248():53-65. PubMed ID: 3671420
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for colorectal cancer.
    Robinson MH; Berry DP; Vellacott KD; Moshakis V; Hardcastle JD
    Lancet; 1993 Jul; 342(8865):241. PubMed ID: 8100960
    [No Abstract]   [Full Text] [Related]  

  • 12. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost of screening for colorectal cancer.
    Walker A; Whynes DK; Chamberlain JO; Hardcastle JD
    J Epidemiol Community Health; 1991 Sep; 45(3):220-4. PubMed ID: 1757765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with screening for colorectal cancer.
    Hoogewerf PE; Burns S; Elwood JM; Hislop TG
    Lancet; 1981 Jul; 2(8238):143. PubMed ID: 6113497
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: optimal compliance with postal faecal occult blood test.
    King J; Fairbrother G; Thompson C; Morris DL
    Aust N Z J Surg; 1992 Sep; 62(9):714-9. PubMed ID: 1520154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.
    Häkkinen I; Paasivuo R; Partanen P
    Gut; 1988 Sep; 29(9):1194-7. PubMed ID: 3197992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for colorectal cancer: an overview.
    Winawer SJ
    Cancer; 1980 Mar; 45(5 Suppl):1093-8. PubMed ID: 7357505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.